These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12071579)

  • 1. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.
    Undas A; Brozek J; Musial J
    Clin Lab; 2002; 48(5-6):287-96. PubMed ID: 12071579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and blood coagulation.
    Undas A; Brummel-Ziedins KE; Mann KG
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early vascular benefits of statin therapy.
    Tsiara S; Elisaf M; Mikhailidis DP
    Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin withdrawal: clinical implications and molecular mechanisms.
    Cubeddu LX; Seamon MJ
    Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current questions regarding the use of statins in patients with coronary heart disease.
    Rallidis LS; Lekakis J; Kremastinos DT
    Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in atherothrombosis.
    Colli S; Werba JP; Tremoli E
    Semin Vasc Med; 2004 Nov; 4(4):407-15. PubMed ID: 15861322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.
    Ray KK; Cannon CP
    J Am Coll Cardiol; 2005 Oct; 46(8):1425-33. PubMed ID: 16226165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy and the management of acute coronary syndromes.
    Langer A; Constance C; Fodor JG; Frohlich JJ; Grégoire J; Lau DC; Leiter LA; Mancini GB; Marr D; McPherson R; O'Neill BJ; Rabkin SW
    Can J Cardiol; 2003 Jul; 19(8):921-7. PubMed ID: 12876613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property.
    Li JJ; Zheng X; Li J
    Med Hypotheses; 2007; 69(2):333-7. PubMed ID: 17215087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
    Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
    Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.